Novavax NVX-CoV2373 COVID-19 vaccine candidate to be manufactured by FDB
Novavax has signed an agreement with FUJIFILM Diosynth Biotechnologies (FDB), a US-based contract development and manufacturing organization (CDMO), for the manufacturing of bulk drug substance for NVX-CoV2373, the former’s COVID-19 vaccine candidate. FUJIFILM Diosynth Biotechnologies’ facility in Morrisville, North Carolina has started production of the first batch of NVX-CoV2373. The arrangement between the two firms […]
The Carlyle Group has signed a deal worth around $490 million with Piramal Enterprises, to acquire a stake of 20% from the Indian conglomerate’s pharma business – Piramal Pharma. The US-based private equity firm will carry out the acquisition through CA Clover Intermediate II Investments, an affiliated entity of CAP V Mauritius, which is an […]
Continue reading …Piramal Pharma acquires solid oral dosage drug product facility in Sellersville
June 20, 2020 No Comment
Piramal Pharma Solutions has agreed to acquire the solid oral dosage drug product manufacturing facility of G&W Laboratories in Sellersville, Pennsylvania for an undisclosed price. A subsidiary of India-based conglomerate Piramal Enterprises, the company is a contract development and manufacturing organization (CDMO), which provides end-to-end development and manufacturing solutions across the drug life cycle. According […]
Continue reading …
Japanese conglomerate AGC has offered a takeover bid of €240 million to acquire 100% of Italian biotech company cum contract development and manufacturing organization (CDMO) Molecular Medicine (Molmed), valuing the latter at €0.518 per share. The clinical-stage Italian biotech company is engaged in research, development, manufacturing and also clinical validation of gene and cell therapies. […]
Continue reading …
Chinese CDMO WuXi Vaccines has signed a 20-year contract worth around $3bn with an undisclosed vaccine company to use a dedicated vaccine manufacturing facility in Ireland to supply commercial vaccine products manufactured from it for the global market. WuXi Vaccines, which is a joint venture between WuXi Biologics and Shanghai Hile Bio-technology, had announced an […]
Continue reading …Catalent Pharma Solutions acquires cell and gene therapy CDMO MaSTherCell
February 11, 2020 No Comment
Drug manufacturer Catalent Pharma Solutions has wrapped up its previously announced $315 million acquisition of MaSTherCell Global, a technology-focused cell and gene therapy contract development and manufacturing organization (cell and gene therapy CDMO). The acquisition, which was announced earlier this month, is said to position Catalent as a major technology, development, and manufacturing partner for […]
Continue reading …
Recipharm acquisition of Consort Medical : Swedish pharma group Recipharm has agreed to acquire Consort Medical, a British contract development and manufacturing organization (CDMO) for £505 million, as per the latest pharma acquisition news. The transaction is said to help Recipharm become a major inhalation company and places it among the top five CDMO players […]
Continue reading …Mallinckrodt to sell Canadian CDMO BioVectra to H.I.G. Capital for $250m
September 12, 2019 No Comment
Mallinckrodt sale of BioVectra to H.I.G. Capital : Irish biopharma company Mallinckrodt has agreed to divest its wholly-owned subsidiary BioVectra, a Canadian CDMO (contract development and manufacturing organization) to an affiliate of H.I.G. Capital for nearly US$250 million, as per the latest pharma acquisition news. The transaction amount to be paid by H.I.G. Capital, which is […]
Continue reading …
Permira acquisition of Cambrex : Global investment firm Permira Funds, through one of its affiliates, has agreed to acquire US contract development and manufacturing organization (US CDMO) Cambrex for about $2.4 billion, including the assumption of its net debt. Based in New Jersey, Cambrex is a small molecule company that offers drug substance, drug product, and […]
Continue reading …
Thermo Fisher acquisition of Brammer Bio : Thermo Fisher Scientific, a global life sciences company, has agreed to buy US-based viral vector contract development and manufacturing organization (CDMO) Brammer Bio for $1.7 billion in an all-cash transaction. Thermo Fisher acquisition of Brammer Bio Brammer Bio, which is owned by Ampersand Capital Partners, is focused on […]
Continue reading …
Business News Today
- MedCrypt acquires medical device cybersecurity software firm MedISAO
- Improving acquires custom software development firm Object Partners
- High Street Insurance acquires Michigan-based Capital Insurance Group
- Mill Creek Residential breaks ground on Modera Washington in Houston
- Cincinnati-based RIA Lenox Wealth Management acquired by Creative Planning
- Jersey Elevator acquired by Arcline Investment Management
- U.S. Gold acquires Northern Panther Resource, owner of Challis gold project
- Perrigo acquires skincare and hair loss treatment brands from Sanofi
- Bayer to acquire KaNDy Therapeutics to add menopause drug candidate
- Thoma Bravo to acquire US insurtech Majesco for higher price of $729m
